Physician profile
Arif N Ali
NPI 1962686238
$584.54
in general payments reported to CMS, 2019-2025
13 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $61.79 · 2024: $149 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $132.14 | 2024-2025 | Varian Ethos Treatment Planning, Bravos Afterloader System |
| Novocure INC. | $130.72 | 2019 | |
| Boston Scientific Corporation | $105.00 | 2020-2025 | Spaceoar Vue System - 10ml |
| Reflexion Medical, INC. | $30.13 | 2024 | Reflexion Medical Radiotherapy System |
| E.R. Squibb & Sons, L.L.C. | $30.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.16 | 2025 | |
| Eisai INC. | $24.46 | 2019 | |
| Elekta, INC. | $18.69 | 2024 | Elekta Medical Linear Accelerator |
| Bayer Healthcare Pharmaceuticals INC. | $18.14 | 2019 | |
| Amgen INC. | $17.83 | 2019 | |
| Incyte Corporation | $17.23 | 2025 | Zynyz, Monjuvi |
| Fortovia Therapeutics, INC. | $16.37 | 2019 | |
| Seagen INC. | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.